Skip to main content

Cryoablation of Liver Tumors

  • Reference work entry
  • First Online:
Image-Guided Cancer Therapy

Abstract

Cryoablation refers to the destruction of tissues by rapid freezing and has been used in the treatment of both metastatic and primary hepatic tumors for several decades. Historically, cryoablation was performed in an open surgical setting and was shown to be an efficacious and generally safe treatment. However, severe but relatively infrequent complications did occur. These early complications led to a better understanding of the biochemistry and predisposing factors that led to the complications. This improved understanding allowed for better patient selection as well as improved post treatment care in avoiding or managing complications. While certain complications, including thrombocytopenia, hemorrhage and cryoshock, are unique to or more common in cryoablation than other ablative modalities, most of these complications are now readily treatable or can be avoided with proper patient screening. Recent technological advances have allowed for cryoablation to be performed percutaneously under imaging guidance. Cryoablation zones are exceptionally well visualized using MR or CT. The precision of cryoablation zone monitoring afforded by CT or MRI guidance provides the operator a degree of intraprocedural confidence regarding ablation zone margins and safety that is not generally possible with other ablation technologies. The placement and powering of individual cryoprobes allows for greater flexibility in avoiding critical structures as well as creating a sufficient ablation zone margin. Cryoablation also causes less pain than radiofrequency ablation, allowing for tumors near the diaphragm, or in a perihepatic location, to be treated with lower doses of intraprocedural and post-procedural analgesic medications. As the stigma of historical problems associated with surgical cryoablation using old technology recedes, a gradually developing body of experience with newer cryoablation technology applied percutaneously and with optimal imaging guidance is stimulating renewed interest in this minimally invasive treatment option for malignant liver tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 269.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 379.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Mala T. Cryoablation of liver tumours – a review of mechanisms, techniques and clinical outcome. Minimal Invasiv Ther. 2006;15:9–17.

    Article  Google Scholar 

  2. Neel HB, Ketcham AS, Hammond WG. Requisites for successful cryogenic surgery of cancer. Arch Surg. 1971;102:45–8.

    Article  PubMed  Google Scholar 

  3. Stewart GJ, Preketes A, Horton M, Ross WB, Morris DL. Hepatic cryotherapy: double-freeze cycles achieve greater hepatocellular injury in man. Cryobiology. 1995;32:215–9.

    Article  CAS  PubMed  Google Scholar 

  4. Gage AA, Baust J. Mechanisms of tissue injury in cryosurgery. Cryobiology. 1998;37:171–86.

    Article  CAS  PubMed  Google Scholar 

  5. Whittaker DK. Mechanisms of tissue destruction following cryosurgery. Ann Roy Coll Surg Eng. 1984;66:313–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  6. Mazur P. The role of intracellular freezing in the death of cells cooled at supraoptimal rates. Cryobiology. 1977;14:251–72.

    Article  CAS  PubMed  Google Scholar 

  7. Gilbert JC, Onik GM, Hoddick WK, et al. Real time ultrasonic monitoring of hepatic cryosurgery. Cryobiology. 1985;22:319–30.

    Article  CAS  PubMed  Google Scholar 

  8. Onik GM. Cryosurgery of liver cancer. Semin Surg Oncol. 1993;9:309–17.

    Article  CAS  PubMed  Google Scholar 

  9. Ravikumar TS, Steele Jr G, Kane R, King V. Experimental and clinical observations on hepatic cryosurgery for colorectal metastases. Cancer Res. 1991;51:6323–7.

    CAS  PubMed  Google Scholar 

  10. Zhou XD, Tang ZY, Yu YQ, Ma ZC. Clinical evaluation of cryosurgery in the treatment of primary liver cancer: report of 60 cases. Cancer. 1988;61:1889–92.

    Article  CAS  PubMed  Google Scholar 

  11. Wagner JS, Adson MA, Van Heerden AJ, Adson MH, Ilstrup DM. The natural history of hepatic metastases from colorectal cancer: a comparison with resective treatment. Ann Surg. 1984;199:502–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Korpan NN. Hepatic cryosurgery for liver metastases: long-term follow-up. Ann Surg. 1997;225:193–201.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Pearson AS, Frencesco I, Fleming D, et al. Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies. Am J Surg. 1999;178:592–8.

    Article  CAS  PubMed  Google Scholar 

  14. Seifert JK, Morris DL. World survey on the complications of hepatic and prostate cryotherapy. World J Surg. 1999;23:109–14.

    Article  CAS  PubMed  Google Scholar 

  15. Ruers TJM, Joosten J, Jager GJ, Wobbes J. Long-term results of treating hepatic colorectal metastases with cryosurgery. Brit J Surg. 2001;88:844–9.

    Article  CAS  PubMed  Google Scholar 

  16. Bilchik AJ, Wood TF, Allegra D, et al. Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms: a proposed algorithm. Arch Surg. 2000;135:657–64.

    Article  CAS  PubMed  Google Scholar 

  17. Kerkar S, Carlin AM, Sohn RL, et al. Long-term follow up and prognostic factors for cryotherapy of malignant liver tumors. Surgery. 2004;136:770–9.

    Article  PubMed  Google Scholar 

  18. Nair RT, Silverman SG, Tuncali K, Obuchowski NA, VanSonnenberg E, Shankar S. Biochemical and hematologic alteration following percutaneous cryoablation of liver tumors: experience in 48 procedures. Radiology. 2008;248:303–11.

    Article  PubMed  Google Scholar 

  19. Pistorious GA, Alexander C, Krisch CM, et al. Local platelet trapping as the cause of thrombocytopenia after hepatic cryotherapy. World J Surg. 2005;29:657–61.

    Article  Google Scholar 

  20. Cozzi PJ, Stewart GJ, Morris DL. Thrombocytopenia after hepatic cryotherapy for colorectal metastases: correlates with hepatocellular injury. World J Surg. 1994;18:774–6.

    Article  CAS  PubMed  Google Scholar 

  21. Sohn RL, Carlin AM, Steffes C, et al. The extent of cryosurgery increases the complication rate after hepatic cryoablation. Am Surg. 2003;69:317–22.

    PubMed  Google Scholar 

  22. Wong WS, Patel SC, Cruz FS, Gala DV, Turner AF. Cryosurgery as a treatment for advanced stage hepatocellular carcinoma. Cancer. 1998;82:1268–78.

    Article  CAS  PubMed  Google Scholar 

  23. Ross WB, Horton M, Bertolino P, Morris DL. Cryotherapy of liver tumours: a practical guide. HPB Surg. 1995;8:167–73.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Adam R, Majno P, Castaing D, et al. Treatment of irresectable liver tumours by percutaneous cryosurgery. Br J Surg. 1998;85:1493–4.

    Article  CAS  PubMed  Google Scholar 

  25. Silverman SG, Tuncali K, Morrison PR. MR imaging-guided percutaneous tumor ablation. Acad Radiol. 2005;12:1100–9.

    Article  PubMed  Google Scholar 

  26. Hinshaw JL, Lee FT. Cryoablation for liver cancer. Tech Vasc Interv Rad. 2007;10:47–57.

    Article  Google Scholar 

  27. Permpongkosol S, Nicol TL, Khurana H, et al. Thermal maps around two adjacent cryoprobes creating overlapping ablations in porcine liver, lung and kidney. J Vasc Interv Radiol (JVIR). 2007;18:283–7.

    Article  Google Scholar 

  28. O’Rourke AP, Haemmerich D, Prakash P, Converse MC, Mahvi DM, Webster JG. Current status of liver ablation devices. Expert Rev Med Devices. 2007;4:523–37.

    Article  PubMed  Google Scholar 

  29. Silverman SG, Sun MR, Tuncali K, et al. Three dimensional assessment of MRI-guided percutaneous cryotherapy of liver metastases. AJR Am J Roentgenol. 2004;183:707–12.

    Article  PubMed  Google Scholar 

  30. Silverman SG, Tuncali K, Adams DF, et al. MR imaging-guided percutaneous cryotherapy of liver tumors: initial experience. Radiology. 2000;217:657–64.

    Article  CAS  PubMed  Google Scholar 

  31. Allaf ME, Varkarakis IM, Bhayani SB, Inagaki T, Kavoussi LR, Solomon SB. Pain control requirements for percutaneous ablation of renal tumors: cryoablation versus radiofrequency ablation- initial observations. Radiology. 2005;237:366–70.

    Article  PubMed  Google Scholar 

  32. Tatli S, Acar M, Tuncali K, Morrison PR, Silverman SG. Percutaneous cryoablation techniques and clinical applications. Diagn Interv Radiol. 2010;16:90–5.

    PubMed  Google Scholar 

  33. Soloman LA, Munkarah AR, Vorugu VR, et al. Image-guided percutaneous cryotherapy for the management of gynecologic cancer metastases. Gynecol Oncol. 2008;111:202–7.

    Article  Google Scholar 

  34. Xu KC, Niu LZ, He WB, et al. Percutaneous cryoablation in combination with ethanol injection for unresectable hepatocellular carcinoma. World J Gastroenterol. 2003;9:2686–9.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Xu KC, Niu LZ, He WB, Hu YZ, Zuo JS. Percutaneous cryosurgery for the treatment of hepatic colorectal metastases. World J Gastroenterol. 2008;14:1430–6.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Xu KJ, Niu LZ, Zhou Q, et al. Sequential use of transarterial chemoembolization and percutaneous cryosurgery for hepatocellular carcinoma. World J Gastroenterol. 2009;15:3664–9.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Adam R, Hagopian EJ, Linhares M, et al. A comparison of percutaneous cryosurgery and percutaneous radiofrequency for unresectable hepatic malignancies. Arch Surg. 2002;137:1332–9.

    Article  PubMed  Google Scholar 

  38. Shock SA, Laeseke PF, Sampson LA, et al. Hepatic hemorrhage caused by percutaneous tumor ablation: radiofrequency ablation versus cryoablation in a porcine model. Radiology. 2005;236:125–31.

    Article  PubMed  Google Scholar 

  39. Adam RA, Akpinar E, Johann M, Kunstlinger F, Majno P, Bismuth H. Place of cryosurgery in the treatment of malignant liver tumors. Ann Surg. 1997;225:39–50.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Wang H, Littrup PJ, Duan Y, et al. Thoracic masses treated with percutaneous cryotherapy: initial experience with more than 200 procedures. Radiology. 2005;235:289–98.

    Article  PubMed  Google Scholar 

  41. McLoughlin RF, Saliken JF, McKinnon G, Wiseman D, Temple W. CT of the liver after cryotherapy of hepatic metastases: imaging findings. AJR Am J Roentgenol. 1995;165:329–32.

    Article  CAS  PubMed  Google Scholar 

  42. Tacke J, Adam G, Haage P, Sellhaus B, Grobkortenhaus S, Gunther RW. MR-guided percutaneous cryotherapy of the liver: in vivo evaluation with histologic correlation in an animal model. J Magn Reson Imaging (JMRI). 2001;13:50–6.

    Article  CAS  Google Scholar 

  43. Kuszyk BS, Boitnott JK, Choti MA, et al. Local tumor recurrence following hepatic cryoablation: radiologic-histopathologic correlation in a rabbit model. Radiology. 2000;217:477–86.

    Article  CAS  PubMed  Google Scholar 

  44. Porter CA, Woodrum DA, Callstrom MR, et al. MRI after technically successful renal cryoablation: early contrast enhancement as a common finding. AJR Am J Roentgenol. 2010;194:790–3.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Paul B. Shyn .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this entry

Cite this entry

Hutchinson, M.J., Shyn, P.B., Silverman, S.G. (2013). Cryoablation of Liver Tumors. In: Dupuy, D., Fong, Y., McMullen, W. (eds) Image-Guided Cancer Therapy. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0751-6_35

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-0751-6_35

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-0750-9

  • Online ISBN: 978-1-4419-0751-6

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics